INKT
MiNK Therapeutics (INKT)
$59
About MiNK Therapeutics (INKT)
MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.
Details
Daily high
$11.91
Daily low
$10.99
Price at open
$11.59
52 Week High
$76.00
52 Week Low
$4.56
Market cap
54.4M
Dividend yield
0.00%
Volume
32,134
Avg. volume
19,959
P/E ratio
-3.82
MiNK Therapeutics News
Details
Daily high
$11.91
Daily low
$10.99
Price at open
$11.59
52 Week High
$76.00
52 Week Low
$4.56
Market cap
54.4M
Dividend yield
0.00%
Volume
32,134
Avg. volume
19,959
P/E ratio
-3.82